Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate Cancer In many countries, cancer treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results